0001415889-24-007230.txt : 20240307 0001415889-24-007230.hdr.sgml : 20240307 20240307195426 ACCESSION NUMBER: 0001415889-24-007230 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240301 FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lehman David Aaron CENTRAL INDEX KEY: 0001354228 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39562 FILM NUMBER: 24731995 MAIL ADDRESS: STREET 1: C/O INTERSECT ENT, INC. STREET 2: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pulmonx Corp CENTRAL INDEX KEY: 0001127537 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-364-0400 MAIL ADDRESS: STREET 1: 700 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER COMPANY: FORMER CONFORMED NAME: PULMONX DATE OF NAME CHANGE: 20001031 4/A 1 form4a-03082024_120320.xml X0508 4/A 2024-03-01 2024-03-05 0001127537 Pulmonx Corp LUNG 0001354228 Lehman David Aaron C/O PULMONX CORPORATION 700 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 false true false false GENERAL COUNSEL 0 Common Stock 2024-03-01 4 A 0 69100 0 A 214588 D Employee Stock Option (right to buy) 9.30 2024-03-01 4 A 0 34500 0 A 2034-02-28 Common Stock 34500 34500 D Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024. The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024. This amendment is being filed solely to correct the inadvertent typographical errors in the number of shares underlying the Employee Stock Option and Restricted Stock Units and the total securities owned after such transactions as reported in the original Form 4 filed with the SEC on March 5, 2024. /s/ Lauren Cristina, Attorney-in-Fact 2024-03-07